May 15 |
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
|
May 15 |
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
|
May 15 |
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
|
May 15 |
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
|
May 15 |
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
|
May 15 |
These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now
|
May 14 |
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
|
May 14 |
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
|
May 14 |
Lilly target price raised at Argus on Mounjaro, Zepbound sales
|
May 14 |
2 Top Pharma Stocks That Just Keep Getting Better and Better
|